Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Equine Veterinary Therapeutics Market Outlook (2023 to 2033)

The global equine veterinary therapeutics market is expected to expand significantly and generate revenue of US$ 2,671.9 million by 2033 from US$ 1,378.7 million in 2023. This increase in revenue is made with an impressive CAGR value of 6.8%.

Historically the equine veterinary therapeutics market is generated US$ 1,307.6 million in 2022. There is expanding popularity of horse activities like racing and jumping which makes demand for equine veterinary therapeutics for care and treatment for horses if any horse gets any injury in these activities.
Equine veterinary therapy is a broad word that covers a wide range of horse therapies. These medicines have the potential to prevent, diagnose, and cure a wide range of diseases and medical conditions.

Horse owners are investing a large amount of money in the health of their animals as they are becoming more aware of the importance of care and treatment of their horses which brings the growth of the equine veterinary therapeutics market.

Regulations governing the use of horse veterinary medications have been established by governments. These rules are intended to ensure both the security and the effectiveness of these health care products. This is predicted to support the expansion of the equine veterinary treatments market, as owners of animals will be more willing to utilize medications that have received approval from the government.

Report Attribute Details
Equine Veterinary Therapeutics Market Value (2023) US$ 1,378.7 million
Equine Veterinary Therapeutics Market Anticipated Forecast Value (2033) US$ 2,671.9 million
Equine Veterinary Therapeutics Market Projected Growth Rate (2023 to 2033) 6.8%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Historical Insights of Global Equine Veterinary Therapeutics Market (2017 to 2022)

The global equine veterinary therapeutics market expanded significantly from a revenue of US$ 1,052.2 million in 2017 to US$ 1,307.6 million in 2022 with an impressive CAGR of 4.4% during the historical period 2017 to 2022.

The global equestrian sports business is quickly expanding, which is fueling demand for equine veterinarian services. Horses are utilized in many sports, such as racing, show jumping, and dressage. These activities necessitate horses in peak physical condition, which increases the demand for preventative and therapeutic veterinary services.

Innovative Growth Strategies by Key Players to Thrive in the Competition

  • Educate the public about equine health.
  • Make use of digital platforms to reach a wider audience and provide better customer service.
  • Develop new vaccines that are effective against emerging diseases.
  • Focusing on customer satisfaction by offering demanded products, high-quality products and services.
  • Expand in new markets to get new customers from new markets.

Investment Opportunities in the Industry

  • Investing in research and development can stay ahead of the competition and meet the needs of horse owners and veterinarians.
  • Investing in partnerships with other organizations helps to develop new products and services, and to reach a wider audience.
  • Invest in sales and marketing, which will help to get more customers.

Regional Insights

The Rise of Equine Veterinary Therapeutics in North America

North America is the largest horse veterinary treatments market, accounting for 30.7% value share in global market. It is likely to expand more in the next decade. The veterinary treatments market in North America is expanding due to increased demand for anti-infectives, vaccinations, pain medications, digestive aids, and the strong research and development industry in North America, are driving the market.

Country The United States
2022 value share in Global Market 24.7%

The Future of Equine Veterinary Therapeutics in Europe

The European market for horse veterinary medications is extremely fragmented and has a value share of 35.2% in 2022, with many small and medium-sized businesses. However, a few huge international corporations play a significant influence in the industry. Many Europe companies manufacture horse goods including immunizations, antibiotics, anti-inflammatory medicines, and pain medications.

Country United Kingdom
Value CAGR (2023 to 2033) 4.8%
Country Germany
2022 value share in Global Market 6.2%

Asia Pacific is Riding the Wave of Growth in the Equine Veterinary Therapeutics Market

The adoption of technology is also playing a significant role in the growth of the Asia Pacific equine veterinary therapeutics market. New technologies are being developed that have the potential to transform the treatment of horse illnesses, like gene therapy, immunotherapy, and customized medicine. These technologies are projected to play a significant role in market growth in the future years in the region.

Country Japan
2022 value share in Global Market 4.4%
Country Value CAGR (2023 to 2033)
China 8.3%
India 6.8%
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Segment-wise Insights

Segment Name Segment Share
Topical 43.2
Veterinary Clinics 40.5

With the increased demand for anti-infectives, pain relievers, and digestive aid products, the topical section of the veterinary treatments market is expanding and has a segment share of 43.2%. The rising frequency of infectious illnesses, rising prevalence of chronic diseases, and rising pet obesity rates are all boosting demand for these items.

With rising demand for surgery, diagnostic testing, and preventive care, the veterinary clinics sector of the veterinary treatments market is expanding and has a segment share of 40.5%. The rising prevalence of animal injuries and diseases, the increased availability of diagnostic testing, and the expanding understanding of the value of preventative treatment are all boosting demand for these services.

Recent Developments

  • January 2023: Apoquel Tablets have been launched by Zoetis Inc. for the relief of atopic dermatitis in dogs and cats. Apoquel is a topical drug that acts by inhibiting the function of interleukin-13, a type of protein that is implicated in the growth of allergic skin irritation.
  • February 2023: Clavamox Soluble Oral Suspension has been launched by Boehringer Ingelheim Animal Health for the prevention and management of respiratory diseases in horses. Clavamox Soluble is a combined antibiotic that works against a variety of bacteria that cause respiratory infections in horses.
  • April 2023: Convenia Injectable Suspension has been launched by Elanco Animal Health for the relief of respiratory diseases in horses. Convenia is a powerful antibiotic that works against a variety of bacteria which may lead to respiratory infections in horses.
  • September 2022: Merck Animal Health has introduced Credelio Spot-On for flea and tick treatment in dogs. Credelio is a monthly spot-on therapy which is simple to use and works well against these types of parasites.
  • December 2022: Merck Animal Health has introduced Bravecto Topical Gel to fight fleas and ticks in cats. Bravecto is a monthly topical gel which is simple to use and offers good parasite prevention.

The Key Players in the Equine Veterinary Therapeutics Market

  • Merck Animal Heath
  • Affymetrix
  • Elanco Animal Health
  • Zoetis (Pfizer Animal Health)
  • Equine Health UK

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Segments Profiled in the Equine Veterinary Therapeutics Market Survey

By Drugs:

  • Anti- Inflammatory
  • Anti - Infective
  • Parasiticides
  • Others

By Vaccines:

  • Recombinant vaccines
  • Inactivated Vaccines
  • Live attenuated vaccines
  • Others

By Feed Additives:

  • Vitamins
  • Antibiotics
  • Amino acids
  • Enzymes
  • Others

By Route of Administration:

  • Oral
  • Parental
  • Topical

By Distribution Channel:

  • Veterinary Hospital
  • Veterinary Clinics
  • Pharmacies and drug stores
  • E-commerce
  • Other

By Region:

  • North America
  • Latin America
  • The Asia Pacific
  • MEA
  • Europe

Frequently Asked Questions

What is the growth rate of the equine veterinary therapeutics market from 2023 to 2033?

The equine veterinary therapeutics market is expected to expand at a CAGR of 6.8% from 2023 to 2033.

Which region is leading the global equine veterinary therapeutics market?

North America is the leading region in the global equine veterinary therapeutics market.

What is the market size of the global equine veterinary therapeutics market in 2023?

The global equine veterinary therapeutics market was valued at US$ 1,378.7 million in 2023.

What does the anticipated revenue of the equine veterinary therapeutics market until 2033?

The anticipated revenue of the equine veterinary therapeutics market until 2033 is US$ 2,671.9 million.

Which are some prominent equine veterinary therapeutics market manufacturers?

Zoetis, Boehringer Ingelheim, Merck Animal Health, Virbac, Elanco Animal Health, and Ceva Animal Health are prominent market manufacturers.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drugs

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Drugs, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Drugs, 2023 to 2033

        5.3.1. Anti- Inflammatory

        5.3.2. Anti – Infective

        5.3.3. Parasiticides

        5.3.4. Others

    5.4. Y-o-Y Growth Trend Analysis By Drugs, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Drugs, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Vaccines

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Vaccines, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Vaccines, 2023 to 2033

        6.3.1. Recombinant vaccines

        6.3.2. Inactivated Vaccines

        6.3.3. Live attenuated vaccines

        6.3.4. Others

    6.4. Y-o-Y Growth Trend Analysis By Vaccines, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Vaccines, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Feed Additives

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Feed Additives, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Feed Additives, 2023 to 2033

        7.3.1. Vitamins

        7.3.2. Antibiotics

        7.3.3. Amino acids

        7.3.4. Enzymes

        7.3.5. Others

    7.4. Y-o-Y Growth Trend Analysis By Feed Additives, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By Feed Additives, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Route of Administration

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) Analysis By Route of Administration, 2018 to 2022

    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Route of Administration, 2023 to 2033

        8.3.1. Oral

        8.3.2. Parental

        8.3.3. Topical

    8.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2018 to 2022

    8.5. Absolute $ Opportunity Analysis By Route of Administration, 2023 to 2033

9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Distribution Channel

    9.1. Introduction / Key Findings

    9.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2018 to 2022

    9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033

        9.3.1. Veterinary Hospital

        9.3.2. Veterinary Clinics

        9.3.3. Pharmacies and drug stores

        9.3.4. E-commerce

        9.3.5. Other

    9.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018 to 2022

    9.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033

10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    10.1. Introduction

    10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Western Europe

        10.3.4. Eastern Europe

        10.3.5. South Asia and Pacific

        10.3.6. East Asia

        10.3.7. Middle East and Africa

    10.4. Market Attractiveness Analysis By Region

11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. USA

            11.2.1.2. Canada

        11.2.2. By Drugs

        11.2.3. By Vaccines

        11.2.4. By Feed Additives

        11.2.5. By Route of Administration

        11.2.6. By Distribution Channel

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Drugs

        11.3.3. By Vaccines

        11.3.4. By Feed Additives

        11.3.5. By Route of Administration

        11.3.6. By Distribution Channel

    11.4. Key Takeaways

12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Brazil

            12.2.1.2. Mexico

            12.2.1.3. Rest of Latin America

        12.2.2. By Drugs

        12.2.3. By Vaccines

        12.2.4. By Feed Additives

        12.2.5. By Route of Administration

        12.2.6. By Distribution Channel

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Drugs

        12.3.3. By Vaccines

        12.3.4. By Feed Additives

        12.3.5. By Route of Administration

        12.3.6. By Distribution Channel

    12.4. Key Takeaways

13. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. Germany

            13.2.1.2. UK

            13.2.1.3. France

            13.2.1.4. Spain

            13.2.1.5. Italy

            13.2.1.6. Rest of Western Europe

        13.2.2. By Drugs

        13.2.3. By Vaccines

        13.2.4. By Feed Additives

        13.2.5. By Route of Administration

        13.2.6. By Distribution Channel

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Drugs

        13.3.3. By Vaccines

        13.3.4. By Feed Additives

        13.3.5. By Route of Administration

        13.3.6. By Distribution Channel

    13.4. Key Takeaways

14. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. Poland

            14.2.1.2. Russia

            14.2.1.3. Czech Republic

            14.2.1.4. Romania

            14.2.1.5. Rest of Eastern Europe

        14.2.2. By Drugs

        14.2.3. By Vaccines

        14.2.4. By Feed Additives

        14.2.5. By Route of Administration

        14.2.6. By Distribution Channel

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Drugs

        14.3.3. By Vaccines

        14.3.4. By Feed Additives

        14.3.5. By Route of Administration

        14.3.6. By Distribution Channel

    14.4. Key Takeaways

15. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. India

            15.2.1.2. Bangladesh

            15.2.1.3. Australia

            15.2.1.4. New Zealand

            15.2.1.5. Rest of South Asia and Pacific

        15.2.2. By Drugs

        15.2.3. By Vaccines

        15.2.4. By Feed Additives

        15.2.5. By Route of Administration

        15.2.6. By Distribution Channel

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Drugs

        15.3.3. By Vaccines

        15.3.4. By Feed Additives

        15.3.5. By Route of Administration

        15.3.6. By Distribution Channel

    15.4. Key Takeaways

16. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        16.2.1. By Country

            16.2.1.1. China

            16.2.1.2. Japan

            16.2.1.3. South Korea

        16.2.2. By Drugs

        16.2.3. By Vaccines

        16.2.4. By Feed Additives

        16.2.5. By Route of Administration

        16.2.6. By Distribution Channel

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Drugs

        16.3.3. By Vaccines

        16.3.4. By Feed Additives

        16.3.5. By Route of Administration

        16.3.6. By Distribution Channel

    16.4. Key Takeaways

17. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    17.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    17.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        17.2.1. By Country

            17.2.1.1. GCC Countries

            17.2.1.2. South Africa

            17.2.1.3. Israel

            17.2.1.4. Rest of MEA

        17.2.2. By Drugs

        17.2.3. By Vaccines

        17.2.4. By Feed Additives

        17.2.5. By Route of Administration

        17.2.6. By Distribution Channel

    17.3. Market Attractiveness Analysis

        17.3.1. By Country

        17.3.2. By Drugs

        17.3.3. By Vaccines

        17.3.4. By Feed Additives

        17.3.5. By Route of Administration

        17.3.6. By Distribution Channel

    17.4. Key Takeaways

18. Key Countries Market Analysis

    18.1. USA

        18.1.1. Pricing Analysis

        18.1.2. Market Share Analysis, 2022

            18.1.2.1. By Drugs

            18.1.2.2. By Vaccines

            18.1.2.3. By Feed Additives

            18.1.2.4. By Route of Administration

            18.1.2.5. By Distribution Channel

    18.2. Canada

        18.2.1. Pricing Analysis

        18.2.2. Market Share Analysis, 2022

            18.2.2.1. By Drugs

            18.2.2.2. By Vaccines

            18.2.2.3. By Feed Additives

            18.2.2.4. By Route of Administration

            18.2.2.5. By Distribution Channel

    18.3. Brazil

        18.3.1. Pricing Analysis

        18.3.2. Market Share Analysis, 2022

            18.3.2.1. By Drugs

            18.3.2.2. By Vaccines

            18.3.2.3. By Feed Additives

            18.3.2.4. By Route of Administration

            18.3.2.5. By Distribution Channel

    18.4. Mexico

        18.4.1. Pricing Analysis

        18.4.2. Market Share Analysis, 2022

            18.4.2.1. By Drugs

            18.4.2.2. By Vaccines

            18.4.2.3. By Feed Additives

            18.4.2.4. By Route of Administration

            18.4.2.5. By Distribution Channel

    18.5. Germany

        18.5.1. Pricing Analysis

        18.5.2. Market Share Analysis, 2022

            18.5.2.1. By Drugs

            18.5.2.2. By Vaccines

            18.5.2.3. By Feed Additives

            18.5.2.4. By Route of Administration

            18.5.2.5. By Distribution Channel

    18.6. UK

        18.6.1. Pricing Analysis

        18.6.2. Market Share Analysis, 2022

            18.6.2.1. By Drugs

            18.6.2.2. By Vaccines

            18.6.2.3. By Feed Additives

            18.6.2.4. By Route of Administration

            18.6.2.5. By Distribution Channel

    18.7. France

        18.7.1. Pricing Analysis

        18.7.2. Market Share Analysis, 2022

            18.7.2.1. By Drugs

            18.7.2.2. By Vaccines

            18.7.2.3. By Feed Additives

            18.7.2.4. By Route of Administration

            18.7.2.5. By Distribution Channel

    18.8. Spain

        18.8.1. Pricing Analysis

        18.8.2. Market Share Analysis, 2022

            18.8.2.1. By Drugs

            18.8.2.2. By Vaccines

            18.8.2.3. By Feed Additives

            18.8.2.4. By Route of Administration

            18.8.2.5. By Distribution Channel

    18.9. Italy

        18.9.1. Pricing Analysis

        18.9.2. Market Share Analysis, 2022

            18.9.2.1. By Drugs

            18.9.2.2. By Vaccines

            18.9.2.3. By Feed Additives

            18.9.2.4. By Route of Administration

            18.9.2.5. By Distribution Channel

    18.10. Poland

        18.10.1. Pricing Analysis

        18.10.2. Market Share Analysis, 2022

            18.10.2.1. By Drugs

            18.10.2.2. By Vaccines

            18.10.2.3. By Feed Additives

            18.10.2.4. By Route of Administration

            18.10.2.5. By Distribution Channel

    18.11. Russia

        18.11.1. Pricing Analysis

        18.11.2. Market Share Analysis, 2022

            18.11.2.1. By Drugs

            18.11.2.2. By Vaccines

            18.11.2.3. By Feed Additives

            18.11.2.4. By Route of Administration

            18.11.2.5. By Distribution Channel

    18.12. Czech Republic

        18.12.1. Pricing Analysis

        18.12.2. Market Share Analysis, 2022

            18.12.2.1. By Drugs

            18.12.2.2. By Vaccines

            18.12.2.3. By Feed Additives

            18.12.2.4. By Route of Administration

            18.12.2.5. By Distribution Channel

    18.13. Romania

        18.13.1. Pricing Analysis

        18.13.2. Market Share Analysis, 2022

            18.13.2.1. By Drugs

            18.13.2.2. By Vaccines

            18.13.2.3. By Feed Additives

            18.13.2.4. By Route of Administration

            18.13.2.5. By Distribution Channel

    18.14. India

        18.14.1. Pricing Analysis

        18.14.2. Market Share Analysis, 2022

            18.14.2.1. By Drugs

            18.14.2.2. By Vaccines

            18.14.2.3. By Feed Additives

            18.14.2.4. By Route of Administration

            18.14.2.5. By Distribution Channel

    18.15. Bangladesh

        18.15.1. Pricing Analysis

        18.15.2. Market Share Analysis, 2022

            18.15.2.1. By Drugs

            18.15.2.2. By Vaccines

            18.15.2.3. By Feed Additives

            18.15.2.4. By Route of Administration

            18.15.2.5. By Distribution Channel

    18.16. Australia

        18.16.1. Pricing Analysis

        18.16.2. Market Share Analysis, 2022

            18.16.2.1. By Drugs

            18.16.2.2. By Vaccines

            18.16.2.3. By Feed Additives

            18.16.2.4. By Route of Administration

            18.16.2.5. By Distribution Channel

    18.17. New Zealand

        18.17.1. Pricing Analysis

        18.17.2. Market Share Analysis, 2022

            18.17.2.1. By Drugs

            18.17.2.2. By Vaccines

            18.17.2.3. By Feed Additives

            18.17.2.4. By Route of Administration

            18.17.2.5. By Distribution Channel

    18.18. China

        18.18.1. Pricing Analysis

        18.18.2. Market Share Analysis, 2022

            18.18.2.1. By Drugs

            18.18.2.2. By Vaccines

            18.18.2.3. By Feed Additives

            18.18.2.4. By Route of Administration

            18.18.2.5. By Distribution Channel

    18.19. Japan

        18.19.1. Pricing Analysis

        18.19.2. Market Share Analysis, 2022

            18.19.2.1. By Drugs

            18.19.2.2. By Vaccines

            18.19.2.3. By Feed Additives

            18.19.2.4. By Route of Administration

            18.19.2.5. By Distribution Channel

    18.20. South Korea

        18.20.1. Pricing Analysis

        18.20.2. Market Share Analysis, 2022

            18.20.2.1. By Drugs

            18.20.2.2. By Vaccines

            18.20.2.3. By Feed Additives

            18.20.2.4. By Route of Administration

            18.20.2.5. By Distribution Channel

    18.21. GCC Countries

        18.21.1. Pricing Analysis

        18.21.2. Market Share Analysis, 2022

            18.21.2.1. By Drugs

            18.21.2.2. By Vaccines

            18.21.2.3. By Feed Additives

            18.21.2.4. By Route of Administration

            18.21.2.5. By Distribution Channel

    18.22. South Africa

        18.22.1. Pricing Analysis

        18.22.2. Market Share Analysis, 2022

            18.22.2.1. By Drugs

            18.22.2.2. By Vaccines

            18.22.2.3. By Feed Additives

            18.22.2.4. By Route of Administration

            18.22.2.5. By Distribution Channel

    18.23. Israel

        18.23.1. Pricing Analysis

        18.23.2. Market Share Analysis, 2022

            18.23.2.1. By Drugs

            18.23.2.2. By Vaccines

            18.23.2.3. By Feed Additives

            18.23.2.4. By Route of Administration

            18.23.2.5. By Distribution Channel

19. Market Structure Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Market Share Analysis of Top Players

        19.3.1. By Regional

        19.3.2. By Drugs

        19.3.3. By Vaccines

        19.3.4. By Feed Additives

        19.3.5. By Route of Administration

        19.3.6. By Distribution Channel

20. Competition Analysis

    20.1. Competition Deep Dive

        20.1.1. Merck Animal Heath

            20.1.1.1. Overview

            20.1.1.2. Product Portfolio

            20.1.1.3. Profitability by Market Segments

            20.1.1.4. Sales Footprint

            20.1.1.5. Strategy Overview

                20.1.1.5.1. Marketing Strategy

        20.1.2. Affymetrix

            20.1.2.1. Overview

            20.1.2.2. Product Portfolio

            20.1.2.3. Profitability by Market Segments

            20.1.2.4. Sales Footprint

            20.1.2.5. Strategy Overview

                20.1.2.5.1. Marketing Strategy

        20.1.3. Elanco Animal Health

            20.1.3.1. Overview

            20.1.3.2. Product Portfolio

            20.1.3.3. Profitability by Market Segments

            20.1.3.4. Sales Footprint

            20.1.3.5. Strategy Overview

                20.1.3.5.1. Marketing Strategy

        20.1.4. Zoetis (Pfizer Animal Health)

            20.1.4.1. Overview

            20.1.4.2. Product Portfolio

            20.1.4.3. Profitability by Market Segments

            20.1.4.4. Sales Footprint

            20.1.4.5. Strategy Overview

                20.1.4.5.1. Marketing Strategy

        20.1.5. Equine Health UK

            20.1.5.1. Overview

            20.1.5.2. Product Portfolio

            20.1.5.3. Profitability by Market Segments

            20.1.5.4. Sales Footprint

            20.1.5.5. Strategy Overview

                20.1.5.5.1. Marketing Strategy

        20.1.6. Olympia Equine Veterinary Services PLLC

            20.1.6.1. Overview

            20.1.6.2. Product Portfolio

            20.1.6.3. Profitability by Market Segments

            20.1.6.4. Sales Footprint

            20.1.6.5. Strategy Overview

                20.1.6.5.1. Marketing Strategy

        20.1.7. Ceva Sante Animale

            20.1.7.1. Overview

            20.1.7.2. Product Portfolio

            20.1.7.3. Profitability by Market Segments

            20.1.7.4. Sales Footprint

            20.1.7.5. Strategy Overview

                20.1.7.5.1. Marketing Strategy

        20.1.8. Eli Lilly and Company

            20.1.8.1. Overview

            20.1.8.2. Product Portfolio

            20.1.8.3. Profitability by Market Segments

            20.1.8.4. Sales Footprint

            20.1.8.5. Strategy Overview

                20.1.8.5.1. Marketing Strategy

        20.1.9. Virbac

            20.1.9.1. Overview

            20.1.9.2. Product Portfolio

            20.1.9.3. Profitability by Market Segments

            20.1.9.4. Sales Footprint

            20.1.9.5. Strategy Overview

                20.1.9.5.1. Marketing Strategy

        20.1.10. Bayer AG

            20.1.10.1. Overview

            20.1.10.2. Product Portfolio

            20.1.10.3. Profitability by Market Segments

            20.1.10.4. Sales Footprint

            20.1.10.5. Strategy Overview

                20.1.10.5.1. Marketing Strategy

21. Assumptions & Acronyms Used

22. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033

Table 2: Global Market Value (US$ Million) Forecast by Drugs, 2018 to 2033

Table 3: Global Market Value (US$ Million) Forecast by Vaccines, 2018 to 2033

Table 4: Global Market Value (US$ Million) Forecast by Feed Additives, 2018 to 2033

Table 5: Global Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033

Table 6: Global Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033

Table 7: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 8: North America Market Value (US$ Million) Forecast by Drugs, 2018 to 2033

Table 9: North America Market Value (US$ Million) Forecast by Vaccines, 2018 to 2033

Table 10: North America Market Value (US$ Million) Forecast by Feed Additives, 2018 to 2033

Table 11: North America Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033

Table 12: North America Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033

Table 13: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 14: Latin America Market Value (US$ Million) Forecast by Drugs, 2018 to 2033

Table 15: Latin America Market Value (US$ Million) Forecast by Vaccines, 2018 to 2033

Table 16: Latin America Market Value (US$ Million) Forecast by Feed Additives, 2018 to 2033

Table 17: Latin America Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033

Table 18: Latin America Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033

Table 19: Western Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 20: Western Europe Market Value (US$ Million) Forecast by Drugs, 2018 to 2033

Table 21: Western Europe Market Value (US$ Million) Forecast by Vaccines, 2018 to 2033

Table 22: Western Europe Market Value (US$ Million) Forecast by Feed Additives, 2018 to 2033

Table 23: Western Europe Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033

Table 24: Western Europe Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033

Table 25: Eastern Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 26: Eastern Europe Market Value (US$ Million) Forecast by Drugs, 2018 to 2033

Table 27: Eastern Europe Market Value (US$ Million) Forecast by Vaccines, 2018 to 2033

Table 28: Eastern Europe Market Value (US$ Million) Forecast by Feed Additives, 2018 to 2033

Table 29: Eastern Europe Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033

Table 30: Eastern Europe Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033

Table 31: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 32: South Asia and Pacific Market Value (US$ Million) Forecast by Drugs, 2018 to 2033

Table 33: South Asia and Pacific Market Value (US$ Million) Forecast by Vaccines, 2018 to 2033

Table 34: South Asia and Pacific Market Value (US$ Million) Forecast by Feed Additives, 2018 to 2033

Table 35: South Asia and Pacific Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033

Table 36: South Asia and Pacific Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033

Table 37: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 38: East Asia Market Value (US$ Million) Forecast by Drugs, 2018 to 2033

Table 39: East Asia Market Value (US$ Million) Forecast by Vaccines, 2018 to 2033

Table 40: East Asia Market Value (US$ Million) Forecast by Feed Additives, 2018 to 2033

Table 41: East Asia Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033

Table 42: East Asia Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033

Table 43: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2018 to 2033

Table 44: Middle East and Africa Market Value (US$ Million) Forecast by Drugs, 2018 to 2033

Table 45: Middle East and Africa Market Value (US$ Million) Forecast by Vaccines, 2018 to 2033

Table 46: Middle East and Africa Market Value (US$ Million) Forecast by Feed Additives, 2018 to 2033

Table 47: Middle East and Africa Market Value (US$ Million) Forecast by Route of Administration, 2018 to 2033

Table 48: Middle East and Africa Market Value (US$ Million) Forecast by Distribution Channel, 2018 to 2033
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Market Value (US$ Million) by Drugs, 2023 to 2033

Figure 2: Global Market Value (US$ Million) by Vaccines, 2023 to 2033

Figure 3: Global Market Value (US$ Million) by Feed Additives, 2023 to 2033

Figure 4: Global Market Value (US$ Million) by Route of Administration, 2023 to 2033

Figure 5: Global Market Value (US$ Million) by Distribution Channel, 2023 to 2033

Figure 6: Global Market Value (US$ Million) by Region, 2023 to 2033

Figure 7: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033

Figure 8: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 9: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 10: Global Market Value (US$ Million) Analysis by Drugs, 2018 to 2033

Figure 11: Global Market Value Share (%) and BPS Analysis by Drugs, 2023 to 2033

Figure 12: Global Market Y-o-Y Growth (%) Projections by Drugs, 2023 to 2033

Figure 13: Global Market Value (US$ Million) Analysis by Vaccines, 2018 to 2033

Figure 14: Global Market Value Share (%) and BPS Analysis by Vaccines, 2023 to 2033

Figure 15: Global Market Y-o-Y Growth (%) Projections by Vaccines, 2023 to 2033

Figure 16: Global Market Value (US$ Million) Analysis by Feed Additives, 2018 to 2033

Figure 17: Global Market Value Share (%) and BPS Analysis by Feed Additives, 2023 to 2033

Figure 18: Global Market Y-o-Y Growth (%) Projections by Feed Additives, 2023 to 2033

Figure 19: Global Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033

Figure 20: Global Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033

Figure 21: Global Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033

Figure 22: Global Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033

Figure 23: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 24: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 25: Global Market Attractiveness by Drugs, 2023 to 2033

Figure 26: Global Market Attractiveness by Vaccines, 2023 to 2033

Figure 27: Global Market Attractiveness by Feed Additives, 2023 to 2033

Figure 28: Global Market Attractiveness by Route of Administration, 2023 to 2033

Figure 29: Global Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 30: Global Market Attractiveness by Region, 2023 to 2033

Figure 31: North America Market Value (US$ Million) by Drugs, 2023 to 2033

Figure 32: North America Market Value (US$ Million) by Vaccines, 2023 to 2033

Figure 33: North America Market Value (US$ Million) by Feed Additives, 2023 to 2033

Figure 34: North America Market Value (US$ Million) by Route of Administration, 2023 to 2033

Figure 35: North America Market Value (US$ Million) by Distribution Channel, 2023 to 2033

Figure 36: North America Market Value (US$ Million) by Country, 2023 to 2033

Figure 37: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 38: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 39: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 40: North America Market Value (US$ Million) Analysis by Drugs, 2018 to 2033

Figure 41: North America Market Value Share (%) and BPS Analysis by Drugs, 2023 to 2033

Figure 42: North America Market Y-o-Y Growth (%) Projections by Drugs, 2023 to 2033

Figure 43: North America Market Value (US$ Million) Analysis by Vaccines, 2018 to 2033

Figure 44: North America Market Value Share (%) and BPS Analysis by Vaccines, 2023 to 2033

Figure 45: North America Market Y-o-Y Growth (%) Projections by Vaccines, 2023 to 2033

Figure 46: North America Market Value (US$ Million) Analysis by Feed Additives, 2018 to 2033

Figure 47: North America Market Value Share (%) and BPS Analysis by Feed Additives, 2023 to 2033

Figure 48: North America Market Y-o-Y Growth (%) Projections by Feed Additives, 2023 to 2033

Figure 49: North America Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033

Figure 50: North America Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033

Figure 51: North America Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033

Figure 52: North America Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033

Figure 53: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 54: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 55: North America Market Attractiveness by Drugs, 2023 to 2033

Figure 56: North America Market Attractiveness by Vaccines, 2023 to 2033

Figure 57: North America Market Attractiveness by Feed Additives, 2023 to 2033

Figure 58: North America Market Attractiveness by Route of Administration, 2023 to 2033

Figure 59: North America Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 60: North America Market Attractiveness by Country, 2023 to 2033

Figure 61: Latin America Market Value (US$ Million) by Drugs, 2023 to 2033

Figure 62: Latin America Market Value (US$ Million) by Vaccines, 2023 to 2033

Figure 63: Latin America Market Value (US$ Million) by Feed Additives, 2023 to 2033

Figure 64: Latin America Market Value (US$ Million) by Route of Administration, 2023 to 2033

Figure 65: Latin America Market Value (US$ Million) by Distribution Channel, 2023 to 2033

Figure 66: Latin America Market Value (US$ Million) by Country, 2023 to 2033

Figure 67: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 68: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 69: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 70: Latin America Market Value (US$ Million) Analysis by Drugs, 2018 to 2033

Figure 71: Latin America Market Value Share (%) and BPS Analysis by Drugs, 2023 to 2033

Figure 72: Latin America Market Y-o-Y Growth (%) Projections by Drugs, 2023 to 2033

Figure 73: Latin America Market Value (US$ Million) Analysis by Vaccines, 2018 to 2033

Figure 74: Latin America Market Value Share (%) and BPS Analysis by Vaccines, 2023 to 2033

Figure 75: Latin America Market Y-o-Y Growth (%) Projections by Vaccines, 2023 to 2033

Figure 76: Latin America Market Value (US$ Million) Analysis by Feed Additives, 2018 to 2033

Figure 77: Latin America Market Value Share (%) and BPS Analysis by Feed Additives, 2023 to 2033

Figure 78: Latin America Market Y-o-Y Growth (%) Projections by Feed Additives, 2023 to 2033

Figure 79: Latin America Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033

Figure 80: Latin America Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033

Figure 81: Latin America Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033

Figure 82: Latin America Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033

Figure 83: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 84: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 85: Latin America Market Attractiveness by Drugs, 2023 to 2033

Figure 86: Latin America Market Attractiveness by Vaccines, 2023 to 2033

Figure 87: Latin America Market Attractiveness by Feed Additives, 2023 to 2033

Figure 88: Latin America Market Attractiveness by Route of Administration, 2023 to 2033

Figure 89: Latin America Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 90: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 91: Western Europe Market Value (US$ Million) by Drugs, 2023 to 2033

Figure 92: Western Europe Market Value (US$ Million) by Vaccines, 2023 to 2033

Figure 93: Western Europe Market Value (US$ Million) by Feed Additives, 2023 to 2033

Figure 94: Western Europe Market Value (US$ Million) by Route of Administration, 2023 to 2033

Figure 95: Western Europe Market Value (US$ Million) by Distribution Channel, 2023 to 2033

Figure 96: Western Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 97: Western Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 98: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 99: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 100: Western Europe Market Value (US$ Million) Analysis by Drugs, 2018 to 2033

Figure 101: Western Europe Market Value Share (%) and BPS Analysis by Drugs, 2023 to 2033

Figure 102: Western Europe Market Y-o-Y Growth (%) Projections by Drugs, 2023 to 2033

Figure 103: Western Europe Market Value (US$ Million) Analysis by Vaccines, 2018 to 2033

Figure 104: Western Europe Market Value Share (%) and BPS Analysis by Vaccines, 2023 to 2033

Figure 105: Western Europe Market Y-o-Y Growth (%) Projections by Vaccines, 2023 to 2033

Figure 106: Western Europe Market Value (US$ Million) Analysis by Feed Additives, 2018 to 2033

Figure 107: Western Europe Market Value Share (%) and BPS Analysis by Feed Additives, 2023 to 2033

Figure 108: Western Europe Market Y-o-Y Growth (%) Projections by Feed Additives, 2023 to 2033

Figure 109: Western Europe Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033

Figure 110: Western Europe Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033

Figure 111: Western Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033

Figure 112: Western Europe Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033

Figure 113: Western Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 114: Western Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 115: Western Europe Market Attractiveness by Drugs, 2023 to 2033

Figure 116: Western Europe Market Attractiveness by Vaccines, 2023 to 2033

Figure 117: Western Europe Market Attractiveness by Feed Additives, 2023 to 2033

Figure 118: Western Europe Market Attractiveness by Route of Administration, 2023 to 2033

Figure 119: Western Europe Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 120: Western Europe Market Attractiveness by Country, 2023 to 2033

Figure 121: Eastern Europe Market Value (US$ Million) by Drugs, 2023 to 2033

Figure 122: Eastern Europe Market Value (US$ Million) by Vaccines, 2023 to 2033

Figure 123: Eastern Europe Market Value (US$ Million) by Feed Additives, 2023 to 2033

Figure 124: Eastern Europe Market Value (US$ Million) by Route of Administration, 2023 to 2033

Figure 125: Eastern Europe Market Value (US$ Million) by Distribution Channel, 2023 to 2033

Figure 126: Eastern Europe Market Value (US$ Million) by Country, 2023 to 2033

Figure 127: Eastern Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 128: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 129: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 130: Eastern Europe Market Value (US$ Million) Analysis by Drugs, 2018 to 2033

Figure 131: Eastern Europe Market Value Share (%) and BPS Analysis by Drugs, 2023 to 2033

Figure 132: Eastern Europe Market Y-o-Y Growth (%) Projections by Drugs, 2023 to 2033

Figure 133: Eastern Europe Market Value (US$ Million) Analysis by Vaccines, 2018 to 2033

Figure 134: Eastern Europe Market Value Share (%) and BPS Analysis by Vaccines, 2023 to 2033

Figure 135: Eastern Europe Market Y-o-Y Growth (%) Projections by Vaccines, 2023 to 2033

Figure 136: Eastern Europe Market Value (US$ Million) Analysis by Feed Additives, 2018 to 2033

Figure 137: Eastern Europe Market Value Share (%) and BPS Analysis by Feed Additives, 2023 to 2033

Figure 138: Eastern Europe Market Y-o-Y Growth (%) Projections by Feed Additives, 2023 to 2033

Figure 139: Eastern Europe Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033

Figure 140: Eastern Europe Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033

Figure 141: Eastern Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033

Figure 142: Eastern Europe Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033

Figure 143: Eastern Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 144: Eastern Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 145: Eastern Europe Market Attractiveness by Drugs, 2023 to 2033

Figure 146: Eastern Europe Market Attractiveness by Vaccines, 2023 to 2033

Figure 147: Eastern Europe Market Attractiveness by Feed Additives, 2023 to 2033

Figure 148: Eastern Europe Market Attractiveness by Route of Administration, 2023 to 2033

Figure 149: Eastern Europe Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 150: Eastern Europe Market Attractiveness by Country, 2023 to 2033

Figure 151: South Asia and Pacific Market Value (US$ Million) by Drugs, 2023 to 2033

Figure 152: South Asia and Pacific Market Value (US$ Million) by Vaccines, 2023 to 2033

Figure 153: South Asia and Pacific Market Value (US$ Million) by Feed Additives, 2023 to 2033

Figure 154: South Asia and Pacific Market Value (US$ Million) by Route of Administration, 2023 to 2033

Figure 155: South Asia and Pacific Market Value (US$ Million) by Distribution Channel, 2023 to 2033

Figure 156: South Asia and Pacific Market Value (US$ Million) by Country, 2023 to 2033

Figure 157: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 158: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 159: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 160: South Asia and Pacific Market Value (US$ Million) Analysis by Drugs, 2018 to 2033

Figure 161: South Asia and Pacific Market Value Share (%) and BPS Analysis by Drugs, 2023 to 2033

Figure 162: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Drugs, 2023 to 2033

Figure 163: South Asia and Pacific Market Value (US$ Million) Analysis by Vaccines, 2018 to 2033

Figure 164: South Asia and Pacific Market Value Share (%) and BPS Analysis by Vaccines, 2023 to 2033

Figure 165: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Vaccines, 2023 to 2033

Figure 166: South Asia and Pacific Market Value (US$ Million) Analysis by Feed Additives, 2018 to 2033

Figure 167: South Asia and Pacific Market Value Share (%) and BPS Analysis by Feed Additives, 2023 to 2033

Figure 168: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Feed Additives, 2023 to 2033

Figure 169: South Asia and Pacific Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033

Figure 170: South Asia and Pacific Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033

Figure 171: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033

Figure 172: South Asia and Pacific Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033

Figure 173: South Asia and Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 174: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 175: South Asia and Pacific Market Attractiveness by Drugs, 2023 to 2033

Figure 176: South Asia and Pacific Market Attractiveness by Vaccines, 2023 to 2033

Figure 177: South Asia and Pacific Market Attractiveness by Feed Additives, 2023 to 2033

Figure 178: South Asia and Pacific Market Attractiveness by Route of Administration, 2023 to 2033

Figure 179: South Asia and Pacific Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 180: South Asia and Pacific Market Attractiveness by Country, 2023 to 2033

Figure 181: East Asia Market Value (US$ Million) by Drugs, 2023 to 2033

Figure 182: East Asia Market Value (US$ Million) by Vaccines, 2023 to 2033

Figure 183: East Asia Market Value (US$ Million) by Feed Additives, 2023 to 2033

Figure 184: East Asia Market Value (US$ Million) by Route of Administration, 2023 to 2033

Figure 185: East Asia Market Value (US$ Million) by Distribution Channel, 2023 to 2033

Figure 186: East Asia Market Value (US$ Million) by Country, 2023 to 2033

Figure 187: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 188: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 189: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 190: East Asia Market Value (US$ Million) Analysis by Drugs, 2018 to 2033

Figure 191: East Asia Market Value Share (%) and BPS Analysis by Drugs, 2023 to 2033

Figure 192: East Asia Market Y-o-Y Growth (%) Projections by Drugs, 2023 to 2033

Figure 193: East Asia Market Value (US$ Million) Analysis by Vaccines, 2018 to 2033

Figure 194: East Asia Market Value Share (%) and BPS Analysis by Vaccines, 2023 to 2033

Figure 195: East Asia Market Y-o-Y Growth (%) Projections by Vaccines, 2023 to 2033

Figure 196: East Asia Market Value (US$ Million) Analysis by Feed Additives, 2018 to 2033

Figure 197: East Asia Market Value Share (%) and BPS Analysis by Feed Additives, 2023 to 2033

Figure 198: East Asia Market Y-o-Y Growth (%) Projections by Feed Additives, 2023 to 2033

Figure 199: East Asia Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033

Figure 200: East Asia Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033

Figure 201: East Asia Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033

Figure 202: East Asia Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033

Figure 203: East Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 204: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 205: East Asia Market Attractiveness by Drugs, 2023 to 2033

Figure 206: East Asia Market Attractiveness by Vaccines, 2023 to 2033

Figure 207: East Asia Market Attractiveness by Feed Additives, 2023 to 2033

Figure 208: East Asia Market Attractiveness by Route of Administration, 2023 to 2033

Figure 209: East Asia Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 210: East Asia Market Attractiveness by Country, 2023 to 2033

Figure 211: Middle East and Africa Market Value (US$ Million) by Drugs, 2023 to 2033

Figure 212: Middle East and Africa Market Value (US$ Million) by Vaccines, 2023 to 2033

Figure 213: Middle East and Africa Market Value (US$ Million) by Feed Additives, 2023 to 2033

Figure 214: Middle East and Africa Market Value (US$ Million) by Route of Administration, 2023 to 2033

Figure 215: Middle East and Africa Market Value (US$ Million) by Distribution Channel, 2023 to 2033

Figure 216: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033

Figure 217: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2018 to 2033

Figure 218: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 219: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 220: Middle East and Africa Market Value (US$ Million) Analysis by Drugs, 2018 to 2033

Figure 221: Middle East and Africa Market Value Share (%) and BPS Analysis by Drugs, 2023 to 2033

Figure 222: Middle East and Africa Market Y-o-Y Growth (%) Projections by Drugs, 2023 to 2033

Figure 223: Middle East and Africa Market Value (US$ Million) Analysis by Vaccines, 2018 to 2033

Figure 224: Middle East and Africa Market Value Share (%) and BPS Analysis by Vaccines, 2023 to 2033

Figure 225: Middle East and Africa Market Y-o-Y Growth (%) Projections by Vaccines, 2023 to 2033

Figure 226: Middle East and Africa Market Value (US$ Million) Analysis by Feed Additives, 2018 to 2033

Figure 227: Middle East and Africa Market Value Share (%) and BPS Analysis by Feed Additives, 2023 to 2033

Figure 228: Middle East and Africa Market Y-o-Y Growth (%) Projections by Feed Additives, 2023 to 2033

Figure 229: Middle East and Africa Market Value (US$ Million) Analysis by Route of Administration, 2018 to 2033

Figure 230: Middle East and Africa Market Value Share (%) and BPS Analysis by Route of Administration, 2023 to 2033

Figure 231: Middle East and Africa Market Y-o-Y Growth (%) Projections by Route of Administration, 2023 to 2033

Figure 232: Middle East and Africa Market Value (US$ Million) Analysis by Distribution Channel, 2018 to 2033

Figure 233: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 234: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 235: Middle East and Africa Market Attractiveness by Drugs, 2023 to 2033

Figure 236: Middle East and Africa Market Attractiveness by Vaccines, 2023 to 2033

Figure 237: Middle East and Africa Market Attractiveness by Feed Additives, 2023 to 2033

Figure 238: Middle East and Africa Market Attractiveness by Route of Administration, 2023 to 2033

Figure 239: Middle East and Africa Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 240: Middle East and Africa Market Attractiveness by Country, 2023 to 2033

Explore Healthcare Insights

View Reports

Equine Veterinary Therapeutics Market